Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1037

YTS169-mIgG2a

Home » Antibodies » YTS169-mIgG2a

Background of YTS169-mIgG2a

CD8 is a glycoprotein present on approximately one-third of T cells in lieu of CD4. Similar to CD4, it binds to a monomorphic region MHC, although it binds to class I rather than to class II antigens. CD8 defines cytotoxic effector cells and perhaps subsets of natural killer and regulatory cells. It facilitates binding between the TCR and class I molecules and is important in protective immune lysis of virally infected parenchymal cells. CD8+ T cells are known to infiltrate allografts and to participate in allograft rejection. Despite this demonstrated role in rejection, CD8 has not been successfully targeted in transplantation, perhaps because CD8+ T cells are recruited late in an alloimmune response and have less regulatory control over immune responses than CD4+ T cells.

Specifications

Catalog Number:
KB-1037
Antibody Name:
YTS169-mIgG2a
Isotype:
Mouse IgG2a,kappa
FC Muations:
Target:
Mouse-CD8
Species Reactivity:
Mouse
Host Cell Line:
EXPI CHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
KD
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C; Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

  1. Gao G, Jakobsen B (2000). "Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor". Immunol Today. 21 (12): 630–6.